Circumsporozoite antibodies and falciparum malaria incidence in children living in a malaria endemic area.
In a case-control study we examined the association of Plasmodium falciparum circumsporozoite antibodies (anti-R32tet32) with subsequent P. falciparum infections. A study population of 140 children living in an endemic area was followed longitudinally for 25 weeks with weekly blood smears for malaria parasites and, once every two weeks, serum samples for circumsporozoite antibody determinations. From the malaria cases, antibody measurements occurring between two and six weeks prior to the onset of parasitaemia were utilized. For each case, two controls were selected. The results from 17 cases and 34 controls failed to show a statistically significant difference in antibody levels prior to the infection (P=0.07, one-tailed Student's t-test). However, 8 of the 17 cases had antibody present, indicating a level that was not protective against patent infection.
D000818:Animals; D000913:Antibodies, Protozoan / Q000032:analysis*; D002648:Child; D006801:Humans; D008137:Longitudinal Studies; D008288:Malaria / Q000276:immunology / Q000469:parasitology*; D010963:Plasmodium falciparum / Q000276:immunology*
D000913:Antibodies, Protozoan